The role of small airways in obstructive airway diseases

This review article is a summary of a seminar organised by the European Respiratory Society on “The role of small airways in obstructive airway diseases” which was held in October 2010 in Amsterdam, the Netherlands. The aims of the seminar were to identify important questions related to small airways involvement in asthma and chronic obstructive pulmonary disease (COPD), and to discuss future approaches based on current and evolving knowledge. Data obtained by pathological and physiological measurements in small airways and their relevance to clinical manifestations and therapeutics in asthma and COPD were reviewed. It was concluded that our knowledge on the roles of small airways in asthma and COPD is limited. Studies of large numbers of well-characterised subjects using multiple methods (genetic characterisation, cell biology and physiology, imaging) and integration of the data using mathematical models are suggested to be of interest. The availability of these techniques coupled with our ability to better target inhaled molecules to small airways provide a unique opportunity for a reappraisal of the relevance of small airways in chronic airway diseases.

[1]  Michael Muskulus,et al.  Fluctuations and determinism of respiratory impedance in asthma and chronic obstructive pulmonary disease. , 2010, Journal of applied physiology.

[2]  A. Paternó,et al.  Effects of extra‐fine inhaled beclomethasone/formoterol on both large and small airways in asthma , 2010, Allergy.

[3]  D. Postma,et al.  Particle size matters: diagnostics and treatment of small airways involvement in asthma , 2010, European Respiratory Journal.

[4]  W. De Backer,et al.  Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. , 2010, Journal of aerosol medicine and pulmonary drug delivery.

[5]  Charles Auffray,et al.  An integrative systems biology approach to understanding pulmonary diseases. , 2010, Chest.

[6]  M. Borchers,et al.  Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice. , 2010, American journal of respiratory and critical care medicine.

[7]  L. Fabbri,et al.  Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. , 2010, The Journal of allergy and clinical immunology.

[8]  S. Verbanck,et al.  Inflammation and airway function in the lung periphery of patients with stable asthma. , 2010, The Journal of allergy and clinical immunology.

[9]  Lior Pachter,et al.  Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.

[10]  N. McElvaney,et al.  Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease. , 2010, American journal of respiratory and critical care medicine.

[11]  Alvar Agusti,et al.  Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.

[12]  G. Colice,et al.  Particle size of inhaled corticosteroids: does it matter? , 2009, The Journal of allergy and clinical immunology.

[13]  Niki Fens,et al.  Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. , 2009, American journal of respiratory and critical care medicine.

[14]  D. Postma,et al.  Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. , 2009, Annals of internal medicine.

[15]  K. Rabe,et al.  Pulmonary periarterial inflammation in fatal asthma , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  J. Hogg,et al.  Micro-computed tomography measurements of peripheral lung pathology in chronic obstructive pulmonary disease. , 2009, Proceedings of the American Thoracic Society.

[17]  H. Kauczor,et al.  Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial , 2009, European Respiratory Journal.

[18]  C. Delacourt,et al.  Update on the roles of distal airways in asthma , 2009, European Respiratory Review.

[19]  A Pedotti,et al.  Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD , 2009, European Respiratory Journal.

[20]  J. Lindeman,et al.  The outer wall of small airways is a major site of remodeling in fatal asthma. , 2009, The Journal of allergy and clinical immunology.

[21]  A. Moreira,et al.  Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema , 2009, European Respiratory Journal.

[22]  Yoshikazu Inoue,et al.  Quantitative CT in chronic obstructive pulmonary disease: inspiratory and expiratory assessment. , 2009, AJR. American journal of roentgenology.

[23]  H. Magnussen,et al.  Lung function and asthma control with beclomethasone and formoterol in a single inhaler. , 2009, Respiratory medicine.

[24]  J. Bates,et al.  Assessment of peripheral lung mechanics , 2008, Respiratory Physiology & Neurobiology.

[25]  P. Laveneziana,et al.  Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD , 2008, Thorax.

[26]  M. Decramer,et al.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[27]  Kunihiro Yagihashi,et al.  Airway dimensions at inspiratory and expiratory multisection CT in chronic obstructive pulmonary disease: correlation with airflow limitation. , 2008, Radiology.

[28]  K. Rabe,et al.  Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma , 2008, European Respiratory Journal.

[29]  Mike Thomas,et al.  Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.

[30]  W. Busse,et al.  Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. , 2008, Journal of applied physiology.

[31]  F. Sciurba,et al.  Autoantibodies in patients with chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[32]  A. Nicholson,et al.  Pharmacological Characterization of Indacaterol, a Novel Once Daily Inhaled β2 Adrenoceptor Agonist, on Small Airways in Human and Rat Precision-Cut Lung Slices , 2008, Journal of Pharmacology and Experimental Therapeutics.

[33]  L. Fabbri,et al.  Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma , 2007, Allergy.

[34]  F. Maltais,et al.  Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial , 2007, Thorax.

[35]  G. Tatsis,et al.  Efficacy of Beclomethasone Dipropionate HFA 200 μg Once Daily in Chronic Obstructive Pulmonary Disease and Bronchial Asthma , 2007, The Journal of international medical research.

[36]  H. Coxson,et al.  Antielastin autoimmunity in tobacco smoking–induced emphysema , 2007, Nature Medicine.

[37]  L. Fabbri,et al.  Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma , 2007, European Respiratory Journal.

[38]  F. Laurent,et al.  Air trapping in mild and moderate asthma: effect of inhaled corticosteroids. , 2007, The Journal of allergy and clinical immunology.

[39]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[40]  S. Muro,et al.  Role of small airways in asthma: investigation using high-resolution computed tomography. , 2006, The Journal of allergy and clinical immunology.

[41]  M. Paiva,et al.  Small airway function improvement after smoking cessation in smokers without airway obstruction. , 2006, American journal of respiratory and critical care medicine.

[42]  M. Paiva,et al.  The functional benefit of anti-inflammatory aerosols in the lung periphery. , 2006, The Journal of allergy and clinical immunology.

[43]  K. Rabe,et al.  Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma , 2006, European Respiratory Journal.

[44]  I. Pavord,et al.  Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. , 2006, American journal of respiratory and critical care medicine.

[45]  C. Prefaut,et al.  Nitrogen washout slope in poorly controlled asthma , 2005, Allergy.

[46]  C. Witt,et al.  Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease. , 2005, Respiratory medicine.

[47]  P. Roughley,et al.  Airway proteoglycans are differentially altered in fatal asthma , 2005, The Journal of pathology.

[48]  Andres Kriete,et al.  Micro-CT of the human lung: imaging of alveoli and virtual endoscopy of an alveolar duct in a normal lung and in a lung with centrilobular emphysema--initial observations. , 2005, Radiology.

[49]  K. Rabe,et al.  Small airways function and molecular markers in exhaled air in mild asthma , 2005, Thorax.

[50]  P. Saldiva,et al.  Inflammatory cell mapping of the respiratory tract in fatal asthma , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[51]  N. Voelkel,et al.  An animal model of autoimmune emphysema. , 2005, American journal of respiratory and critical care medicine.

[52]  L. Grinberg,et al.  Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. , 2004, American journal of respiratory and critical care medicine.

[53]  R. Pauwels,et al.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.

[54]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[55]  N. Siafakas,et al.  Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. , 2004, Chest.

[56]  P. Paré,et al.  Characterization of airway plugging in fatal asthma. , 2003, The American journal of medicine.

[57]  M. Okamoto,et al.  Decreased computed tomographic lung density during exacerbation of asthma , 2003, European Respiratory Journal.

[58]  S. Wenzel,et al.  Transbronchial biopsy as a tool to evaluate small airways in asthma , 2002, European Respiratory Journal.

[59]  D. Price,et al.  Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. , 2002, Chest.

[60]  L. Fabbri,et al.  Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[61]  P. Grenier,et al.  Mild intermittent asthma: CT assessment of bronchial cross-sectional area and lung attenuation at controlled lung volume. , 2002, Radiology.

[62]  M Paiva,et al.  A human acinar structure for simulation of realistic alveolar plateau slopes. , 2000, Journal of applied physiology.

[63]  F. Laurent,et al.  Functional significance of air trapping detected in moderate asthma , 2000, European Radiology.

[64]  P. Sterk,et al.  Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. , 2000, American journal of respiratory and critical care medicine.

[65]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[66]  tefan,et al.  LONG-TERM TREATMENT WITH INHALED BUDESONIDE IN PERSONS WITH MILD CHRONIC OBSTRUCTIVE PULMONARY DISEASE WHO CONTINUE SMOKING , 2000 .

[67]  W. Busse,et al.  Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. , 1999, The Journal of allergy and clinical immunology.

[68]  D. Aberle,et al.  Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. , 1999, The Journal of allergy and clinical immunology.

[69]  W. Maziak,et al.  Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[70]  L. Fabbri,et al.  CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[71]  E. Minshall,et al.  Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. , 1999, The Journal of allergy and clinical immunology.

[72]  R. Djukanović,et al.  Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. , 1999, American journal of respiratory and critical care medicine.

[73]  D. Postma,et al.  Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. , 1999, The New England journal of medicine.

[74]  J G Goldin,et al.  Airway hyperreactivity: assessment with helical thin-section CT. , 1998, Radiology.

[75]  A. Sanna,et al.  Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up. , 1998, Chest.

[76]  N. Tsoukias,et al.  A two-compartment model of pulmonary nitric oxide exchange dynamics. , 1998, Journal of applied physiology.

[77]  E. Minshall,et al.  Cytokine mRNA expression in asthma is not restricted to the large airways. , 1998, The Journal of allergy and clinical immunology.

[78]  L. Fabbri,et al.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[79]  M Paiva,et al.  Ventilation distribution during histamine provocation. , 1997, Journal of applied physiology.

[80]  J. Hogg,et al.  Inflammation of small airways in asthma. , 1997, The Journal of allergy and clinical immunology.

[81]  A. James,et al.  The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. , 1997, The European respiratory journal.

[82]  P. Barnes,et al.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.

[83]  D. Postma,et al.  European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. , 1992, The European respiratory journal.

[84]  M. Ebina,et al.  Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. , 1992, Chest.

[85]  T Takishima,et al.  Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. , 1992, Journal of applied physiology.

[86]  M Paiva,et al.  Model simulations of gas mixing and ventilation distribution in the human lung. , 1990, Journal of applied physiology.

[87]  E. Bleecker,et al.  Peripheral lung resistance in normal and asthmatic subjects. , 1990, The American review of respiratory disease.

[88]  M. Cosio,et al.  Loss of alveolar attachments in smokers. A morphometric correlate of lung function impairment. , 1985, The American review of respiratory disease.

[89]  J. Kleinerman,et al.  Structure and function of small airways in health and disease. , 1978, Archives of pathology & laboratory medicine.

[90]  J Dosman,et al.  The relations between structural changes in small airways and pulmonary-function tests. , 1978, The New England journal of medicine.

[91]  E. R. Mcfadden,et al.  Small airway disease: An assessment of the tests of peripheral airway function , 1974 .

[92]  J. Hogg,et al.  Site and nature of airway obstruction in chronic obstructive lung disease. , 1968, The New England journal of medicine.

[93]  P. Macklem,et al.  Resistance of central and peripheral airways measured by a retrograde catheter. , 1967, Journal of applied physiology.

[94]  M. Dunnill.  THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSA , 1960, Journal of clinical pathology.